This article has been corrected: The Grant section information has been updated with the following logos:
Original article: Oncotarget. 2019; 10:6494–6508. 6494-6508. https://doi.org/10.18632/oncotarget.27303
. 2020 Jul 28;11(30):2958. doi: 10.18632/oncotarget.27685
Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection
Jolein Mijnes
1,✉, Janina Tiedemann
1, Julian Eschenbruch
1, Janina Gasthaus
1, Sarah Bringezu
1, Dirk Bauerschlag
3, Nicolai Maass
3, Norbert Arnold
3,6, Jörg Weimer
3, Tobias Anzeneder
4, Peter A Fasching
5, Matthias Rübner
5, Benjamin Bruno
7, Uwe Heindrichs
7, Jennifer Freres
7, Hanna Schulz
1, Ralf-Dieter Hilgers
8, Nadina Ortiz-Brüchle
1, Sonja von Serenyi
1, Ruth Knüchel
1, Vera Kloten
1,9,*, Edgar Dahl
1,2,*
Jolein Mijnes
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Jolein Mijnes
Janina Tiedemann
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Janina Tiedemann
Julian Eschenbruch
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Julian Eschenbruch
Janina Gasthaus
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Janina Gasthaus
Sarah Bringezu
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Sarah Bringezu
Dirk Bauerschlag
3 Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany
Find articles by Dirk Bauerschlag
Nicolai Maass
3 Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany
Find articles by Nicolai Maass
Norbert Arnold
3 Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany
6 Institute of Clinical Molecular Biology, University Medical Centre Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University, Kiel, Germany
Find articles by Norbert Arnold
Jörg Weimer
3 Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany
Find articles by Jörg Weimer
Tobias Anzeneder
4 Patients' Tumor Bank of Hope (PATH-Biobank) Foundation, München, Germany
Find articles by Tobias Anzeneder
Peter A Fasching
5 Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
Find articles by Peter A Fasching
Matthias Rübner
5 Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
Find articles by Matthias Rübner
Benjamin Bruno
7 Department of Gynecology and Obstetrics Luisenhospital, Aachen, Germany
Find articles by Benjamin Bruno
Uwe Heindrichs
7 Department of Gynecology and Obstetrics Luisenhospital, Aachen, Germany
Find articles by Uwe Heindrichs
Jennifer Freres
7 Department of Gynecology and Obstetrics Luisenhospital, Aachen, Germany
Find articles by Jennifer Freres
Hanna Schulz
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Hanna Schulz
Ralf-Dieter Hilgers
8 Institute of Medical Statistics, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Ralf-Dieter Hilgers
Nadina Ortiz-Brüchle
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Nadina Ortiz-Brüchle
Sonja von Serenyi
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Sonja von Serenyi
Ruth Knüchel
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Find articles by Ruth Knüchel
Vera Kloten
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
9 Current address: Bayer AG, Pharmaceuticals Division, Biomarker Research, Wuppertal, Germany
* Share equal senior authorship
Find articles by Vera Kloten
Edgar Dahl
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
2 RWTH centralized Biomaterial Bank (RWTH cBMB) at the Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
* Share equal senior authorship
Find articles by Edgar Dahl
1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
2 RWTH centralized Biomaterial Bank (RWTH cBMB) at the Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
3 Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany
4 Patients' Tumor Bank of Hope (PATH-Biobank) Foundation, München, Germany
5 Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
6 Institute of Clinical Molecular Biology, University Medical Centre Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University, Kiel, Germany
7 Department of Gynecology and Obstetrics Luisenhospital, Aachen, Germany
8 Institute of Medical Statistics, University Hospital RWTH Aachen, Aachen, Germany
9 Current address: Bayer AG, Pharmaceuticals Division, Biomarker Research, Wuppertal, Germany
* Share equal senior authorship
✉
Correspondence to: Jolein Mijnes, jmijnes@ukaachen.de
Collection date 2020 Jul 28.
Copyright: © 2020 Mijnes et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PMCID: PMC7392623 PMID: 32774775
This corrects the article "SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection" in volume 10 on page 6494.